In Brief ACS and MRA award $2.6 million for research focused on reducing immunotherapy side effects – The Cancer Letter Publications
In Brief ACS and MRA award $2.6 million for research focused on reducing immunotherapy side effectsThe Cancer Letter PublicationsThe American Cancer Society and the Melanoma Research Alliance selected the first group of scientists to receive newly esta… Continue reading
